Portfolio company
ForEndo Pharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops hormone regulation therapies for women with endometriosis and polycystic ovary syndrome.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Gesynta Pharma
This company develops anti-inflammatory and pain-relieving oral pharmaceuticals targeting the mPGES-1 enzyme for patients with endometriosis and chronic inflammatory conditions.
Gesynta
This pharmaceutical company develops non-hormonal oral treatments targeting chronic inflammation and pain for patients with endometriosis and other inflammatory conditions.
Endoriz
Endoriz develops circadian-rhythm mimicking hormonal replacement therapies to treat patients with hypothyroidism and thyroid hormone deficiency.
Endogene.Bio
This company develops a biological data platform using menstrual blood to provide diagnostics and patient stratification tools for pharmaceutical firms and healthcare providers.
Afynia
This company develops non-invasive blood tests to diagnose endometriosis for women and fertility clinics.
Endometrics
Endometrics develops non-invasive diagnostic tests using menstrual blood samples and genomic biomarkers to detect endometriosis for women and healthcare providers.
Ardana
This company develops and markets pharmaceutical products focused on reproductive health for patients and healthcare providers.
Oriva
This clinical-stage biotechnology company develops therapies for chronic gynecological diseases, including endometriosis and uterine fibroids, for women requiring non-hormonal or disease-modifying treatment options.